Amid Clamour for Phase 3 Trials Data, Bharat Biotech Says 'Committed to Transparency'

The complete data for Phase I and II, and partial data for Phase III trials of Covaxin have been thoroughly scrutinised by the regulators in India, Bharat Biotech said in a statement.

from Top Business News- News18.com https://ift.tt/3iBKwCr
via IFTTT